BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19226194)

  • 1. Carbapenem resistance mechanism and risk factors of Pseudomonas aeruginosa clinical isolates from a University Hospital in Xi'an, China.
    Zhang JF; Chen BL; Xin XY; Zhao HB; Wang HY; Song H; Xu ZK
    Microb Drug Resist; 2009 Mar; 15(1):41-5. PubMed ID: 19226194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.
    Quale J; Bratu S; Gupta J; Landman D
    Antimicrob Agents Chemother; 2006 May; 50(5):1633-41. PubMed ID: 16641429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY; Ko KS
    Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
    Tam VH; Chang KT; LaRocco MT; Schilling AN; McCauley SK; Poole K; Garey KW
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital.
    Liu Y; Li XY; Wan LG; Jiang WY; Li FQ; Yang JH
    Microb Drug Resist; 2013 Dec; 19(6):463-8. PubMed ID: 23865862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
    Bubonja-Sonje M; Matovina M; Skrobonja I; Bedenic B; Abram M
    Microb Drug Resist; 2015 Jun; 21(3):261-9. PubMed ID: 25565041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
    Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
    J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
    Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL
    Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
    Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem inactivation: a very affordable and highly specific method for phenotypic detection of carbapenemase-producing Pseudomonas aeruginosa isolates compared with other methods.
    Akhi MT; Khalili Y; Ghotaslou R; Kafil HS; Yousefi S; Nagili B; Goli HR
    J Chemother; 2017 Jun; 29(3):144-149. PubMed ID: 27443547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains.
    Tsai MH; Wu TL; Su LH; Lo WL; Chen CL; Liang YH; Chiu CH
    Int J Antimicrob Agents; 2014 Dec; 44(6):541-5. PubMed ID: 25264129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa.
    Atrissi J; Milan A; Bressan R; Lucafò M; Petix V; Busetti M; Dolzani L; Lagatolla C
    Microbiol Spectr; 2021 Oct; 9(2):e0118621. PubMed ID: 34585948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A carbapenem-susceptible Pseudomonas aeruginosa strain carrying the bla(SPM) gene.
    Pellegrino FL; Casali N; Nouér SA; Riley LW; Moreira BM
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):214-6. PubMed ID: 18308497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.